Diyabetli Hastalarda Psikolojik İnsülin Direnci Ölçeğinin Türkçeye Uyarlanması

Amaç: Bu araştırma, diyabetli hastalarda psikolojik insülin direnci ölçeğinin Türkçeye uyarlanması amacıyla yapıldı. Gereç ve Yöntemler: Metodolojik türde yapılan araştırma için belirlenen minimum örneklem sayısı 180’di (orijinal ölçekte yer alan 18 madde sayısının 10 katı alınarak belirlendi). Araştırma toplam 201 diyabet hastası ile tamamlandı. Veri toplama aracı olarak diyabetli hastaları Tanıtıcı Anket Formu ve Psikolojik İnsülin Direnci Ölçeği kullanıldı. Bulgular: Psikolojik İnsülin Direnci Ölçeğinin faktör analizinde öz değeri 1’in üstünde olan 3 faktörlü (destekleyici, psiko-bilişsel ve fiziksel faktörler) 12 sorudan oluştuğu, toplam varyans değerinin %60,4 olduğu belirlendi. Kaiser-Meyer-Olkin değeri 0,77, Bartlett’s testi X2=877,833, p<0,001 ve Cronbach alfa katsayısı 0,82 olarak hesaplandı. Sonuç: Yapılan geçerlik ve güvenirlik çalışması sonucunda ölçeğin Türk toplumuna uygun ve tip 2 diyabetli hastalarda psikolojik insülin direnci varlığını değerlendirmede geçerli ve güvenilir bir ölçme aracı olduğu belirlendi. Ölçeğin özellikle klinikte çalışan hemşirelerin tip 2 diyabetli hastaları insülin tedavisine karşı psikolojik yönden değerlendirme fırsatı sunmada yararlı olacağı düşünülebilir. Ölçeğin daha büyük örneklem grubu ile çalışılması önerilebilir. 

Turkish Adaptation of Psychological Insulin Resistance Scale in Diabetic Patients

Aim: This study was carried out to Turkish Adaptation of Psychological Insulin Resistance Scale in Diabetic Patients Methods: The minimum number of samples determined for the research conducted in the methodological type is 180 (it was determined by taking 10 times the number of 18 items in the original scale). The study was completed with a total of 201 diabetic patients. Descriptive Questionnaire Form and Psychological Insulin Resistance Scale were used as data collection tools. Results: In the factor analysis of the Psychological Insulin Resistance Scale, it was determined that it consists of 12 questions with 3 factors (supporting, psycho-cognitive and physically factors) with an eigenvalue above 1, and the total variance value was 60.9%. KMO (Kaiser-Meyer-Olkin) value was calculated as 0.77, Bartlett's test X2 = 877.833, p <.001 and Cronbach alpha coefficient 0.82. Conclusion: As a result of the validity and reliability study, it was determineted that the scale is suitable for Turkish society and is a valid and reliable measurement tool for evaluating the presence of psychological insulin resistance in patients with type 2 diabetes. It is thought that especially nurses working in the clinic will be useful in providing the opportunity to evaluate patients psychologically against insulin therapy. It is recommended that the scale should be used to determine psychological insulin resistance in patients with type 2 diabetes and to study with a larger sample group.

___

  • 1. Care D, Suppl SS. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetesd 2019. Diabetes Care. 2019; 42(January):90–102.
  • 2. Attitudes D, Polonsky W. Psychological Insulin Resistance. 1991, 92014, 241–244.
  • 3. Brod M., Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. 2009. Quality of Life Research, 18(1), 23-32.
  • 4. Petrak F, Herpertz S, Stridde E, Pfützner A. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin. Diabetes Technology and Therapeutics. 2013, 15(8), 703–11.
  • 5. Yu JH, Kim HY, Kim SR, Ko E, Jin HY. Factors influencing psychological insulin resistance in type 2 diabetes patients. International journal of nursing practice. 2019, 25(3), e12733.
  • 6. Song Y, Ku BJ, Cho J, Jun Y, Kim B, Nam S. The prevalence of insulin refusal and psychological insulin resistance among Korean patients with type 2 diabetes mellitus. Annals of Translational Medicine. 2019, 7(23), 760.
  • 7. Woudenberg YJC, Lucas C, Latour C, Scholte Op Reimer WJM. Acceptance of insulin therapy: A long shot? Psychological insulin resistance in primary care. Diabetic Medicine. 2012, 29(6), 796–802.
  • 8. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educator. 2006, 32(1 SUPPL.), 9–18. 9. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, Nathan DM. Measuring psychological insulin resistance: barriers to insulin use. The Diabetes Educator. 2008, 34(3), 511–7.
  • 10. Polonsky William H, Hajos TRS, Dain MP, Snoek FJ. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Current Medical Research and Opinion. 2011, 27(6), 1169–74.
  • 11. Polonsky WH, Jackson RA. What’s So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes. Clinical Diabetes. 2004, 22(3), 147–50.
  • 12. Snoek FJ, Skovlund SE, Pouwer F. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health and Quality of Life Outcomes. 2007, 5, 1–7.
  • 13. Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: Patient beliefs and implications for diabetes management. Quality of Life Research. 2009, 18(1), 23–32.
  • 14. Nam S, Nam S, Song Y. Role of Self-Efficacy in the Relationship Between Patient-Provider Relationships and Psychological Insulin Resistance Among Patients with Type 2 Diabetes. Journal of Contemporary Diabetes Research. 2015, 1(1), 1–15.
  • 15. Ng CJ, Lai PSM, Lee YK, Azmi SA, Teo CH. Barriers and facilitators to starting insulin in patients with type 2 diabetes: A systematic review. International Journal of Clinical Practice, 2015, 69(10), 1050–70.
  • 16. Nicolucci A, Kovacs Burns K, Holt RIG, Comaschi M, Hermanns N, Ishii H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M. Diabetes attitudes, wishes and needs second study (DAWN2TM): Cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabetic Medicine. 2013, 30(7), 767–77.
  • 17. Saleem A, Masood I, Khan TM. Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan. Cogent Medicine. 2016, 3(1).
  • 18. Wong S, Lee J, Ko Y, Chong MF, Lam CK, Tang WE. Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabetic Medicine. 2011, 28(2), 206–11.
  • 19. İnkaya BV, Karadağ E. Diyabetli bireyler ve onlara bakım veren hemşirelerin hastalık özyönetim stratejilerine bakışı: Kalitatif bir çalışma. Koç Üniversitesi Hemşirelikte Eğitim ve Araştırma Dergisi (HEAD). 2017, 14(1), 31-7.
  • 20. Bahrmann A, Abel A, Zeyfang A, Petrak F, Kubiak T, Hummel J, Oster P, Bahrmann P. Psychological insulin resistance in geriatric patients with diabetes mellitus. Patient Education and Counseling. 2014, 94(3), 417–22.
  • 21. Kim B, Song Y, Kim JI. Psychological insulin resistance and low self-efficacy as barriers to diabetes self-care management in patients with type 2 diabetes. Korean Journal of Adult Nursing. 2019, 31(1), 61–7.
  • 22. Lim A, Song Y. The role of psychological insulin resistance in diabetes self-care management. Nursing Open. 2020, February, 1–8.
  • 23. Song Y, Jeon Y, Cho J, Kim B. Development of a psychological insulin resistance scale for Korean patients with diabetes. Journal of Korean Academy of Nursing. 2016, 46(6), 813–23.
  • 24. Coşkun S, Bebiş H. Adolesanlarda e-sağlık okuryazarlığı ölçeği: Türkçe geçerlik ve güvenirlik çalışması. Gülhane Tıp Derg. 2015, 57, 378–84.
  • 25. Gümüş H, Özgül SA. Rekreasyon alanı kullanımına ilişkin katılım engelleri ve tercih etkenleri ölçeklerinin geliştirilmesi. Journal of Human Sciences. 2017, 14(1), 865-82.
  • 26. Allen NA, Zagarins SE, Feinberg RG, Welch G. Treating psychological insulin resistance in type 2 diabetes. Journal of Clinical & Translational Endocrinology. 2017, 7, 1-6
  • 27. Kartal M, Bardakçı S. SPSS ve AMOS Uygulamalı Örneklerle Güvenirlik ve Geçerlik Analizleri. Ankara: Akademisyen Yayınevi. 2018
  • 28. Karagöz Y. SPSS 23 ve AMOS 23 uygulamalı istatistiksel analizler. Nobel Akademik Yayıncılık. 2016.
  • 29. Petrak F, Stridde E, Leverkus F, Crispin AA, Forst T, Pfützner A. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care. 2007,30(9) 2199-2204.
  • 30. Saritas SC, Erci B, Sahin I, Timocin E. Validity study of the Turkish version of the barriers to insulin treatment questionnaire. International Journal of Diabetes in Developing Countries. 2019, 39 (2) 247-253.
Turkish Journal of Family Medicine and Primary Care-Cover
  • ISSN: 1307-2048
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2007
  • Yayıncı: -